
IDXX · NASDAQ
IDEXX Laboratories, Inc.
$559.82 -6.87 (-1.21%)
Company overview
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for the biomedical research community.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Exchange
- NASDAQ
- Market cap
- $44.1B
- Employees
- 11,000
- Headquarters
- Westbrook, ME
- Website
- idexx.com
- CEO
- Jonathan J. Mazelsky
- Listed
- June 21, 1991
- P/E
- 40.95
- Dividend yield
- 0.00%
Company financials
- Revenue
- $4.4B
- Gross profit
- $2.8B
- Operating income
- $1.4B
- EBITDA
- $1.5B
- Net income
- $1.1B
- EPS
- $13.67
- Total assets
- $3.4B
- Total debt
- $1.1B
- Gross margin
- 62.05%
- Net margin
- 24.63%
- Earnings yield
- 2.44%
Showing FY 2025